Patent Medicine Market By Type and Application - Global Industry Analysis And Forecast To 2027
Published On : October 2018 Pages : 137 Category: Pharmaceuticals Report Code : HC101492
Patent Medicine Market By Type (Product Patents and Process Patents) and Application (Adult and Children) - Global Industry Analysis And Forecast To 2027
Industry Outlook
The patent medicine is regularly used to allude to an item, (for example, a tonic, liniment, or elixir) which was advertised as the medicine in the U.S. amid the 1800s and mid 1900s yet was commonly of dubious viability and flawed wellbeing. The nonprescription preparation of medicine which is regularly secured by the trademark and whose substance are not completely unveiled. The major benefit associated with this medicine is it gives right of stopping others from manufacturing, copying, importing or selling an invention without the permission of patent holder. Therefore, the Patent Medicine Market is anticipated to expand and has tremendous scope during the forecast period. The global Patent Medicine Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Drivers & Restrains
The driving factors of the global market are; increasing numbers of technical development taking place in the field of medicine related to the patents & various process related to diagnosis & treatment, rising prevalence of various diseases which demands more targeted drugs & therapies for the treatment, rising funding from various public & government sectors to the researchers, rising initiatives by the government to encourage the researchers, and various other factors. The restraining factor of the market can be the strict rules & regulations of the government for some trails related to new inventions on animals as well as humans.
Regional Insights
The North American region is leading the global Patent Medicine Market owing to factor like well-developed healthcare sector, and some other factors.
Patent Medicine Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- GSK
- Pfizer Inc.
- Bristol-Myers Squibb Co.
- Otsuka Pharmaceutical
- Merck
- Sanofi-Aventis
- Novartis
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Patent Medicine Market Classification
o Patent Medicine Patent Medicine Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Product Patents
o Process Patents
o Patent Medicine Patent Medicine Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Adult
o Children
o Patent Medicine Patent Medicine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Patent Medicine Market , By Country
o U.S. Patent Medicine Market
o Canada Patent Medicine Market
o Mexico Patent Medicine Market
o Europe
§ Europe Patent Medicine Market , By Country
o Germany Patent Medicine Market
o UK Patent Medicine Market
o France Patent Medicine Market
o Russia Patent Medicine Market
o Italy Patent Medicine Market
o Rest of Europe Patent Medicine Market
o Asia-Pacific
§ Asia-Pacific Patent Medicine Market , By Country
o China Patent Medicine Market
o Japan Patent Medicine Market
o South Korea Patent Medicine Market
o India Patent Medicine Market
o Southeast Asia Patent Medicine Market
o Rest of Asia-Pacific Patent Medicine Market
o South America
§ South America Patent Medicine Market , By Country
o Brazil Patent Medicine Market
o Argentina Patent Medicine Market
o Columbia Patent Medicine Market
o Rest of South America Patent Medicine Market
o Middle East and Africa
§ Middle East and Africa Patent Medicine Market , By Country
o Saudi Arabia Patent Medicine Market
o UAE Patent Medicine Market
o Egypt Patent Medicine Market
o Nigeria Patent Medicine Market
o South Africa Patent Medicine Market
o Rest of MEA Patent Medicine Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Patent Medicine Market, By Type
5.1. Introduction
5.2. Global Patent Medicine Revenue and Market Share by Type (2017-2027)
5.2.1. Global Patent Medicine Revenue and Revenue Share by Type (2017-2027)
5.3. Process Patents
5.3.1. Global Process Patents Revenue and Growth Rate (2017-2027)
5.4. Product Patents
5.4.1. Global Product Patents Revenue and Growth Rate (2017-2027)
6. Patent Medicine Market, By Application
6.1. Introduction
6.2. Global Patent Medicine Revenue and Market Share by Application (2017-2027)
6.2.1. Global Patent Medicine Revenue and Revenue Share by Application (2017-2027)
6.3. Adult
6.3.1. Global Adult Revenue and Growth Rate (2017-2027)
6.4. Children
6.4.1. Global Children Revenue and Growth Rate (2017-2027)
7. Patent Medicine Market, By Region
7.1. Introduction
7.2. Global Patent Medicine Revenue and Market Share by Regions
7.2.1. Global Patent Medicine Revenue by Regions (2017-2027)
7.3. North America Patent Medicine by Countries
7.3.1. North America Patent Medicine Revenue and Growth Rate (2017-2027)
7.3.2. North America Patent Medicine Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Patent Medicine by Countries
7.4.1. Europe Patent Medicine Revenue and Growth Rate (2017-2027)
7.4.2. Europe Patent Medicine Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Patent Medicine by Countries
7.5.1. Asia-Pacific Patent Medicine Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Patent Medicine Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Patent Medicine by Countries
7.6.1. South America Patent Medicine Revenue and Growth Rate (2017-2027)
7.6.2. South America Patent Medicine Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Patent Medicine by Countries
7.7.1. Middle East and Africa Patent Medicine Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Patent Medicine Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Merck
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Revenue and Market Share
8.2. Pfizer Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Revenue and Market Share
8.3. GSK
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Revenue and Market Share
8.4. Novartis
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Revenue and Market Share
8.5. Otsuka Pharmaceutical
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Revenue and Market Share
8.6. Sanofi-Aventis
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Revenue and Market Share
8.7. Bristol-Myers Squibb Co.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Revenue and Market Share
9. Global Patent Medicine Market Competition, by Manufacturer
9.1. Global Patent Medicine Revenue and Market Share by Manufacturer (2017-2017)
9.2. Top 5 Patent Medicine Manufacturer Market Share
9.3. Market Competition Trend
10. Patent Medicine Market Forecast (2017-2027)
10.1. Global Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Patent Medicine Market Forecast by Regions (2017-2027)
10.2.1. North America Patent Medicine Market Forecast (2017-2027)
10.2.1.1. United States Patent Medicine Market Forecast (2017-2027)
10.2.1.2. Canada Patent Medicine Market Forecast (2017-2027)
10.2.1.3. Mexico Patent Medicine Market Forecast (2017-2027)
10.2.2. Europe Patent Medicine Market Forecast (2017-2027)
10.2.2.1. Germany Patent Medicine Market Forecast (2017-2027)
10.2.2.2. France Patent Medicine Market Forecast (2017-2027)
10.2.2.3. UK Patent Medicine Market Forecast (2017-2027)
10.2.2.4. Russia Patent Medicine Market Forecast (2017-2027)
10.2.2.5. Italy Patent Medicine Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Patent Medicine Market Forecast (2017-2027)
10.2.3. Asia-Pacific Patent Medicine Market Forecast (2017-2027)
10.2.3.1. China Patent Medicine Market Forecast (2017-2027)
10.2.3.2. Japan Patent Medicine Market Forecast (2017-2027)
10.2.3.3. Korea Patent Medicine Market Forecast (2017-2027)
10.2.3.4. India Patent Medicine Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Patent Medicine Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Patent Medicine Market Forecast (2017-2027)
10.2.4. South America Patent Medicine Market Forecast (2017-2027)
10.2.4.1. Brazil Patent Medicine Market Forecast (2017-2027)
10.2.4.2. Argentina Patent Medicine Market Forecast (2017-2027)
10.2.4.3. Columbia Patent Medicine Market Forecast (2017-2027)
10.2.4.4. Rest of South America Patent Medicine Market Forecast (2017-2027)
10.2.5. Middle East and Africa Patent Medicine Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Patent Medicine Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Patent Medicine Market Forecast (2017-2027)
10.2.5.3. Egypt Patent Medicine Market Forecast (2017-2027)
10.2.5.4. Nigeria Patent Medicine Market Forecast (2017-2027)
10.2.5.5. South Africa Patent Medicine Market Forecast (2017-2027)
10.2.5.6. Turkey Patent Medicine Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Patent Medicine Market Forecast (2017-2027)
10.3. Patent Medicine Market Forecast by Type (2017-2027)
10.3.1. Patent Medicine Forecast by Type (2017-2027)
10.3.2. Patent Medicine Market Share Forecast by Type (2017-2027)
10.4. Patent Medicine Market Forecast by Application (2017-2027)
10.4.1. Patent Medicine Forecast by Application (2017-2027)
10.4.2. Patent Medicine Market Share Forecast by Application (2017-2027)
List of Tables
11. List of Tables and Figures
Figure United States Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Patent Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Patent Medicine Revenue and Revenue Share by Type (2017-2018)
Figure Global Process Patents Revenue and Growth Rate (2017-2018)
Figure Global Product Patents Revenue and Growth Rate (2017-2018)
Table Global Patent Medicine Revenue and Revenue Share by Application (2017-2018)
Figure Global Adult Revenue and Growth Rate (2017-2018)
Figure Global Children Revenue and Growth Rate (2017-2018)
Table Global Patent Medicine Revenue by Regions (2017-2018)
Figure North America Patent Medicine Growth Rate (2017-2018)
Figure North America Patent Medicine Revenue and Growth Rate (2017-2018)
Figure North America Patent Medicine by Countries (2017-2018)
Figure North America Patent Medicine Revenue (Million USD) by Countries (2017-2018)
Figure United States Patent Medicine Growth Rate (2017-2018)
Figure United States Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Patent Medicine Growth Rate (2017-2018)
Figure Canada Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Patent Medicine Growth Rate (2017-2018)
Figure Mexico Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Patent Medicine Growth Rate (2017-2018)
Figure Europe Patent Medicine Revenue and Growth Rate (2017-2018)
Figure Europe Patent Medicine by Countries (2017-2018)
Figure Europe Patent Medicine Revenue (Million USD) by Countries (2017-2018)
Figure Germany Patent Medicine Growth Rate (2017-2018)
Figure Germany Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Patent Medicine Growth Rate (2017-2018)
Figure France Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Patent Medicine Growth Rate (2017-2018)
Figure UK Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Patent Medicine Growth Rate (2017-2018)
Figure Russia Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Patent Medicine Growth Rate (2017-2018)
Figure Italy Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Patent Medicine Growth Rate (2017-2018)
Figure Rest of Europe Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Patent Medicine Growth Rate (2017-2018)
Figure Asia-Pacific Patent Medicine Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Patent Medicine by Countries (2017-2018)
Figure Asia-Pacific Patent Medicine Revenue (Million USD) by Countries (2017-2018)
Figure China Patent Medicine Growth Rate (2017-2018)
Figure China Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Patent Medicine Growth Rate (2017-2018)
Figure Japan Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Patent Medicine Growth Rate (2017-2018)
Figure Korea Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Patent Medicine Growth Rate (2017-2018)
Figure India Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Patent Medicine Growth Rate (2017-2018)
Figure Southeast Asia Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Patent Medicine Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Patent Medicine Growth Rate (2017-2018)
Figure South America Patent Medicine Revenue and Growth Rate (2017-2018)
Figure South America Patent Medicine by Countries (2017-2018)
Figure South America Patent Medicine Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Patent Medicine Growth Rate (2017-2018)
Figure Brazil Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Patent Medicine Growth Rate (2017-2018)
Figure Argentina Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Patent Medicine Growth Rate (2017-2018)
Figure Columbia Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Patent Medicine Growth Rate (2017-2018)
Figure Rest of South America Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Patent Medicine Growth Rate (2017-2018)
Figure Middle East and Africa Patent Medicine Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Patent Medicine by Countries (2017-2018)
Figure Middle East and Africa Patent Medicine Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Patent Medicine Growth Rate (2017-2018)
Figure Saudi Arabia Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Patent Medicine Growth Rate (2017-2018)
Figure United Arab Emirates Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Patent Medicine Growth Rate (2017-2018)
Figure Egypt Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Patent Medicine Growth Rate (2017-2018)
Figure Nigeria Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Patent Medicine Growth Rate (2017-2018)
Figure South Africa Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Patent Medicine Growth Rate (2017-2018)
Figure Turkey Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Patent Medicine Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Patent Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Table Merck Patent Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Patent Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GSK Patent Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis Patent Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Otsuka Pharmaceutical Patent Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi-Aventis Patent Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bristol-Myers Squibb Co. Patent Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Patent Medicine Market Share by Manufacturer
Figure Global Patent Medicine Revenue and Market Share by Manufacturer
Figure Top 5 Patent Medicine Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Patent Medicine Revenue (Millions USD) and Growth Rate (2018-2025)
Table Patent Medicine Market Forecast by Regions (2018-2025)
Figure North America Patent Medicine Market Forecast (2018-2025)
Figure United States Patent Medicine Market Forecast (2018-2025)
Figure Canada Patent Medicine Market Forecast (2018-2025)
Figure Mexico Patent Medicine Market Forecast (2018-2025)
Figure Europe Patent Medicine Market Forecast (2018-2025)
Figure Germany Patent Medicine Market Forecast (2018-2025)
Figure France Patent Medicine Market Forecast (2018-2025)
Figure UK Patent Medicine Market Forecast (2018-2025)
Figure Russia Patent Medicine Market Forecast (2018-2025)
Figure Italy Patent Medicine Market Forecast (2018-2025)
Figure Rest of Europe Patent Medicine Market Forecast (2018-2025)
Figure Asia-Pacific Patent Medicine Market Forecast (2018-2025)
Figure China Patent Medicine Market Forecast (2018-2025)
Figure Japan Patent Medicine Market Forecast (2018-2025)
Figure Korea Patent Medicine Market Forecast (2018-2025)
Figure India Patent Medicine Market Forecast (2018-2025)
Figure Southeast Asia Patent Medicine Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Patent Medicine Market Forecast (2018-2025)
Figure South America Patent Medicine Market Forecast (2018-2025)
Figure Brazil Patent Medicine Market Forecast (2018-2025)
Figure Argentina Patent Medicine Market Forecast (2018-2025)
Figure Columbia Patent Medicine Market Forecast (2018-2025)
Figure Rest of South America Patent Medicine Market Forecast (2018-2025)
Figure Middle East and Africa Patent Medicine Market Forecast (2018-2025)
Figure Saudi Arabia Patent Medicine Market Forecast (2018-2025)
Figure United Arab Emirates Patent Medicine Market Forecast (2018-2025)
Figure Egypt Patent Medicine Market Forecast (2018-2025)
Figure Nigeria Patent Medicine Market Forecast (2018-2025)
Figure South Africa Patent Medicine Market Forecast (2018-2025)
Figure Turkey Patent Medicine Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Patent Medicine Market Forecast (2018-2025)
Figure Global Patent Medicine Forecast by Type (2018-2025)
Figure Global Patent Medicine Market Share Forecast by Type (2018-2025)
Figure Global Patent Medicine Forecast by Type (2018-2025)
Figure Global Patent Medicine Forecast by Application (2018-2025)
Figure Global Patent Medicine Market Share Forecast by Application (2018-2025)
Figure Global Patent Medicine Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|